Clinical Trial Update: Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer [NA]

View source ↗

Summary

This document reports a clinical trial update on using omic technologies to track resistance to palbociclib in metastatic breast cancer. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (Ibrance) (palbociclib)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Advanced Breast Cancer | NA | Status: ACTIVE_NOT_RECRUITING